Hypertension genomics and cardiovascular prevention

Area of Science:

• Cardiovascular Genetics
• Genomics
• Hypertension Research

Background:

• Hypertension remains a leading global cause of mortality.
• Recent large-scale genome-wide association studies (GWAS) have identified numerous genetic loci associated with blood pressure regulation.

Purpose of the Study:

• To review the impact of recent cardiovascular GWAS findings.
• To explore the potential of genomics in hypertension management.
• To discuss applications in drug discovery, risk stratification, pharmacogenetics, and gene-environment interactions.

Main Methods:

• Review of the latest and largest cardiovascular genome-wide association studies (GWAS).
• Synthesis of current knowledge on genetic influences on blood pressure.
• Analysis of emerging applications of genomic data in clinical practice.

Main Results:

• GWAS have significantly expanded the number of identified genetic loci influencing blood pressure.
• Genomic insights are paving the way for novel drug targets.
• Genetic risk scores show promise for stratifying individuals by hypertension risk.
• Pharmacogenetics offers potential for personalized drug selection.
• Gene-environment interactions provide deeper understanding of hypertension etiology.

Conclusions:

• Genomics holds transformative potential for understanding and managing hypertension.
• Future research should focus on translating genomic discoveries into clinical applications.
• Personalized approaches to hypertension prevention and treatment are becoming increasingly feasible.